DoW Alzheimer’s Transforming Research Award
Defense Health Agency Contracting Activity - DHACA
Free. Verify your email, then we send one reminder only.
- Posted
- May 1, 2026
- Amount
- Program total $4M
- Closes
- Sep 24, 2026 (in 10 days)
Similar opportunities open now
- DoW Alzheimer’s Transforming Diagnosis AwardSame funderOpenDefense Health Agency Contracting Activity - DHACACloses in 10 days
- DoW Alzheimer’s Transforming Care AwardSame funderOpenDefense Health Agency Contracting Activity - DHACACloses in 10 days
- DoW Traumatic Brain Injury and Psychological Health, Translational Research AwardSame funderOpenDefense Health Agency Contracting Activity - DHACACloses in 31 days
- DoW Reconstructive Transplant, Investigator-Initiated Research AwardSame funderOpenDefense Health Agency Contracting Activity - DHACACloses in 51 days
- DOW Combat Readiness – Medical Research Program Translational Research AwardSame funderOpenDefense Health Agency Contracting Activity - DHACACloses in 65 days
Classification and identifiers
- Solicitation number
- HT942526AZRPTRRA
- Assistance listing (CFDA)
- 12.420
Amount
Program total $4M
Who can apply
About this opportunity
Summary: The fiscal year 2026 (FY26) Alzheimer’s Research Program (AZRP) Transforming Research Award (TrRA) supports non-incremental, robust, well-designed research that drives transformative advancements in reducing risk and preventing the development of Alzheimer’s disease and/or Alzheimer's disease related dementias (AD/ADRD). Distinctive Features: • Applications must address at least one of the following focus areas: ○ Risk Factor Knowledge: Research that advances understanding, identification, and/or validation of risk and/or protective factors, with research outcomes/products focused on accelerating solutions. Projects may include, but are not limited to, research on environmental, epigenetic, genetic, lifestyle, occupational, or other risks not listed here. ○ Risk Reduction Solution...